Metabolic Disease TreatmentMetabolex, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of type II diabetes and related metabolic disorders. The companyâ€™s products include MBX-102/JNJ 39659100, an oral...
Founded in 1991
Total money raised: $40.6M
Phone: (510) 293-8800
Metabolex at CrunchBase
Metabolex raised $8.6M in unattributed round from Alta Partners, Venrock, Versant Ventures, Bay City Capital, VantagePoint Capital Partners, Novo Ventures, KBC Private Equity, Pictet Private Equity Investors S.A., Next Chapter Holdings, Charter Ventures, Merlin Biomed, and Birchmere Ventures
Metabolex raised $32M in a Series D round from AllianceBernstein, Deerfield Capital Management, T. Rowe Price, Alta Partners, Bay City Capital, Birchmere Ventures, Johnson & Johnson Development Corporation, KBC Private Equity, Pictet Private Equity Investors S.A., Merlin Biomed, Novo Ventures, VantagePoint Capital Partners, Venrock, Versant Ventures, Biotech Turnaround Fund (BTF), and MPM Capital
Metabolex was founded in 1991